Pentwater Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Buy
+35,000
New +$14.8M 0.08% 56
2025
Q4
– Sell
-120,000
Closed -$51.1M – 95
2025
Q3
$51.1M Buy
120,000
+5,000
+4% +$1.94M 0.29% 47
2025
Q2
$44.1M Buy
115,000
+25,000
+28% +$9.01M 0.29% 51
2025
Q1
$31.1M Buy
+90,000
New +$28.9M 0.26% 44

Other funds holding HCA

Pentwater Capital Management's HCA Position: Q2 2026 in Review

Pentwater Capital Management increased its HCA Healthcare (HCA) stake by 73% in Q2 2026, buying an estimated $23.3M and bringing the position to 130,000 shares worth $50.7M. The position accounts for 0.31% of the portfolio, ranked #40.

Pentwater Capital Management first reported a position in HCA in Q1 2020 and has held it in 8 quarters since. The position peaked at $108M in Q3 2025. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Pentwater Capital Management held 130,000 shares of HCA Healthcare worth $50.7M as of Q2 2026.
  • Pentwater Capital Management bought 55,000 HCA Healthcare shares in Q2 2026, an estimated $23.3M.
  • HCA Healthcare made up 0.31% of Pentwater Capital Management's portfolio in Q2 2026, its #40 holding.
  • Pentwater Capital Management first reported a position in HCA Healthcare in Q1 2020 and has held it in 8 quarters since.
  • Pentwater Capital Management's HCA Healthcare position peaked at $108M in Q3 2025.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.